Miloš Žarković, Professor. MD, PhD

University of Belgrade
Belgrade, Serbia

Disclosure information not submitted.

Presentation(s):

• SUN-328 - Phase 3 Randomized-Controlled Trials Evaluating Efficacy and Safety of Subcutaneous Efgartigimod PH20 using Pre-Filled Syringes in Patients with Graves' Disease Inadequately Controlled with Antithyroid Drugs: Trials in Progress

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF49-05 - Results from a Phase 1b Trial Evaluating CD40-Ligand Blocker Lu AG22515 in Patients with Moderate-to-Severe Thyroid Eye Disease

  Monday, June 15, 2026
  2:15 PM - 2:30 PM CT